Edgewise Therapeutics, Inc.
SEC Filing List
EWTX CIK: 0001710072
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G | 05/15/2026 | ||||
| 8-K | Current report filing | Edgewise Therapeutics, Inc. | Toppan Merrill/FA | 05/07/2026 | |
| 10-Q | Quarterly report pursuant to Section 13 ... | Edgewise Therapeutics, Inc. | Toppan Merrill/FA | 05/07/2026 | |
| S-8 | Initial registration statement for secur... | Edgewise Therapeutics, Inc. | Toppan Merrill/FA | 05/07/2026 | |
| 144 | Filing for proposed sale of securities u... | Morgan Stanley Smith Barney LLC Executive Services /FA | 05/05/2026 | ||
| 4 | Statement of changes in beneficial owner... | Donovan Joanne M. | Edgewise Therapeutics, Inc. | 05/05/2026 | |
| SCHEDULE 13D/A | 04/27/2026 | ||||
| ARS | Annual report to security holders | Edgewise Therapeutics, Inc. | Toppan Merrill/FA | 04/23/2026 | |
| DEFA14A | Definitive additional proxy soliciting m... | Edgewise Therapeutics, Inc. | Toppan Merrill/FA | 04/23/2026 | |
| DEF 14A | Definitive proxy statements | Edgewise Therapeutics, Inc. | Toppan Merrill/FA | 04/23/2026 | |
| No record found. | |||||
| Load More | |||||
